Results
1
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
1 companies
Gubra
Market Cap: DKK 6.0b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 368.80
7D
-1.7%
1Y
-27.4%